About SynapticureSynapticure aims to provide patients affected by neurodegenerative disorders access to high-quality care while leveraging its broad reach to advance personalized treatments for patients with these diseases. We do so by providing end-to-end clinical care using our telemedicine platform to guide patients through their entire care journey. We are devoted to helping patients and caregivers get the support they need by providing the full spectrum of clinical care relevant to each patient. Synapticure was built by leading patient and caregiver advocates alongside leading clinicians and scientists, biotech executives and telemedicine executives to bring care and treatment experience into the 21st century.
As part of designing cutting edge care, we believe understanding the disease biology of our patients to advance treatment for them is essential. We are leveraging our thorough knowledge of in vitro disease modeling and our novel technology to create a patient-derived platform that will allow us to screen, diagnose and advance therapeutics for ALS and ...